Sameer R. Ghate
-
- Prostate Cancer Treatment and Research 23
- Renal cell carcinoma treatment 9
- Geriatrics and Gerontology top 10%
- Internal Medicine top 10%
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers 11
- PARP inhibition in cancer therapy 10
- Cutaneous Melanoma Detection and Management 7
-
- Cancer Genomics and Diagnostics 7
-
- Melanoma and MAPK Pathways 9
-
- Economic and Financial Impacts of Cancer 7
- Co-authors
- Diana BrixnerJoseph BiskupiakLingfeng YangJamie L. StudtsChristina R. StudtsXiangyang YeA. Scott LaJoieMichael A. Andrykowski
- Journals
- Journal of Clinical Oncology (13 papers)Future Oncology (6 papers)Journal of Managed Care & Specialty Pharmacy (3 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Sameer R. Ghate
61 papers receiving 844 citations
Peers
Comparison fields: 5 of 97
- Pulmonary and Respiratory Medicine 374
- Geriatrics and Gerontology 42
- Internal Medicine 39
- Oncology 255
- Cancer Research 107
Countries citing papers authored by Sameer R. Ghate
This map shows the geographic impact of Sameer R. Ghate's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sameer R. Ghate with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sameer R. Ghate more than expected).
Fields of papers citing papers by Sameer R. Ghate
This network shows the impact of papers produced by Sameer R. Ghate. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sameer R. Ghate. The network helps show where Sameer R. Ghate may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sameer R. Ghate, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2023 | 1 | |
| 5 | 2022 | 16 | |
| 6 | 2021 | 5 | |
| 7 | 2021 | 14 | |
| 8 | 2021 | 54 | |
| 9 | 2020 | 1 | |
| 10 | 2017 | 15 | |
| 11 | 2017 | 53 | |
| 12 | 2017 | 11 | |
| 13 | 2017 | 8 | |
| 14 | 2016 | 1 | |
| 15 | 2014 | 1 | |
| 16 | 2013 | 18 | |
| 17 | 2013 | 13 | |
| 18 | 2012 | 17 | |
| 19 | 2011 | 58 | |
| 20 | 2008 | 8 |
About Sameer R. Ghate
Sameer R. Ghate is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Internal Medicine and Economics and Econometrics, having authored 62 papers that have together received 850 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (23 papers), Cancer Immunotherapy and Biomarkers (11 papers), PARP inhibition in cancer therapy (10 papers), Renal cell carcinoma treatment (9 papers), Melanoma and MAPK Pathways (9 papers), Economic and Financial Impacts of Cancer (7 papers), Cancer Genomics and Diagnostics (7 papers) and Cutaneous Melanoma Detection and Management (7 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (374 citations), Geriatrics and Gerontology (42 citations), Internal Medicine (39 citations), Oncology (255 citations) and Cancer Research (107 citations). Sameer R. Ghate has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Diana Brixner, Joseph Biskupiak, Lingfeng Yang, Jamie L. Studts, Christina R. Studts, Xiangyang Ye, A. Scott LaJoie, Michael A. Andrykowski, Christopher Barnes and Renato V. LaRocca. Their work appears in journals such as Journal of Clinical Oncology, Future Oncology, Journal of Managed Care & Specialty Pharmacy, Clinical Genitourinary Cancer and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.